218 related articles for article (PubMed ID: 11474697)
1. Carvedilol saves lives--new data from landmark trials prove survival benefits in heart failure and post myocardial infarction.
Cardiovasc J S Afr; 2001; 12(2):122-3. PubMed ID: 11474697
[No Abstract] [Full Text] [Related]
2. New evidence from the CAPRICORN Trial: the role of carvedilol in high-risk, post-myocardial infarction patients.
Sackner-Bernstein JD
Rev Cardiovasc Med; 2003; 4 Suppl 3():S25-9. PubMed ID: 14564231
[TBL] [Abstract][Full Text] [Related]
3. The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?
Otterstad JE; Ford I
Eur J Heart Fail; 2002 Aug; 4(4):501-6. PubMed ID: 12167391
[TBL] [Abstract][Full Text] [Related]
4. [Beta blockers in post-infarction state].
Schultheiss HP; Tschöpe C
Herz; 2002 Aug; 27 Suppl 1():26-9. PubMed ID: 12229255
[TBL] [Abstract][Full Text] [Related]
5. Major beta blocker mortality trials in chronic heart failure: a critical review.
McMurray JJ
Heart; 1999 Dec; 82 Suppl 4(Suppl 4):IV14-22. PubMed ID: 10574906
[No Abstract] [Full Text] [Related]
6. Carvedilol for heart failure: more than just a beta-blocker?
Cleland JG
Br J Hosp Med; 1997 Nov 19-Dec 9; 58(10):493-7. PubMed ID: 10193451
[TBL] [Abstract][Full Text] [Related]
7. [Therapy with beta blockers in heart failure. Recent studies of carvedilol].
Böhm M; Erdmann E
Fortschr Med; 1996 May; 114(13):167-8. PubMed ID: 8964561
[No Abstract] [Full Text] [Related]
8. [Congestive heart failure and acute myocardial infarction: latest trials with beta-blocking agents].
Isnard R
Ann Cardiol Angeiol (Paris); 2002 Jan; 51(1):48-50. PubMed ID: 12510669
[No Abstract] [Full Text] [Related]
9. Carvedilol: use in chronic heart failure.
Doughty RN; White HD
Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
[TBL] [Abstract][Full Text] [Related]
10. [Effect of carvedilol on survival in severe chronic heart failure. A trial of the beta-blocker bucindolol in patient with advanced heart failure].
Bosimini E
Ital Heart J Suppl; 2001 Aug; 2(8):919-21. PubMed ID: 11582729
[No Abstract] [Full Text] [Related]
11. Design and methodology of the CAPRICORN trial - a randomised double blind placebo controlled study of the impact of carvedilol on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction.
Dargie HJ
Eur J Heart Fail; 2000 Sep; 2(3):325-32. PubMed ID: 10938495
[No Abstract] [Full Text] [Related]
12. Left ventricular systolic dysfunction in a cardiac transplant recipient treated with carvedilol.
Gardner RS; McGowan J; McDonagh TA
Eur J Heart Fail; 2002 Jun; 4(3):377-9. PubMed ID: 12034165
[TBL] [Abstract][Full Text] [Related]
13. Update on pharmacological advances.
Fonarow G
J Invasive Cardiol; 2004 Sep; 16 Suppl E():2E-6E. PubMed ID: 23573649
[No Abstract] [Full Text] [Related]
14. [Severe heart failure. Carvedilol lowers mortality].
MMW Fortschr Med; 2001 Mar; 143(9):58. PubMed ID: 11288541
[No Abstract] [Full Text] [Related]
15. A comment on COMET: how to interpret a positive trial?
Massie BM
J Card Fail; 2003 Dec; 9(6):425-8. PubMed ID: 14966781
[No Abstract] [Full Text] [Related]
16. Carvedilol in the failing heart.
Lombardi WL; Gilbert EM
Clin Cardiol; 2001 Dec; 24(12):757-66. PubMed ID: 11768738
[TBL] [Abstract][Full Text] [Related]
17. Beta-blockers in heart failure: how far have we progressed?
Adams KF
Postgrad Med; 2002 Nov; 112(5 Suppl Unanswered):7-15. PubMed ID: 19667603
[TBL] [Abstract][Full Text] [Related]
18. Landmark study: the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction Study (CAPRICORN).
Colucci WS
Am J Cardiol; 2004 May; 93(9A):13B-6B. PubMed ID: 15144931
[TBL] [Abstract][Full Text] [Related]
19. Does carvedilol have antiarrhythmic properties?
Naccarelli GV
Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):338-9. PubMed ID: 16265556
[No Abstract] [Full Text] [Related]
20. Effect of carvedilol therapy on functional mitral regurgitation, ventricular remodeling, and contractility in patients with heart failure due to left ventricular systolic dysfunction.
Comin-Colet J; Sánchez-Corral MA; Manito N; Gómez-Hospital JA; Roca J; Fernández-Nofrerias E; Valdovinos P; Esplugas E
Transplant Proc; 2002 Feb; 34(1):177-8. PubMed ID: 11959238
[No Abstract] [Full Text] [Related]
[Next] [New Search]
